Presently, with only 150 machines released worldwide, The Sloane Clinic is proud to announce the availability of Ulthera for the first time in Singapore, exclusively at our clinic
Singapore, Singapore (PRWEB) August 6, 2009
Last season, research in German laser aftercare produced Korean BB creams whilst glaucoma medication unearthed lash-lengthening solutions. Today, a breakthrough in non-ablative aesthetic care stems from tumour cells treatment. Ultherapy™ is an ultrasonic intelligence to push technological boundaries, allowing us to achieve long lasting lifting effects of the skin through ultrasound. Touted as the latest non-surgical facelift, no other modality treats this layer of collagen and elastin fibres of the superficial musculoaponeurotic system (SMAS).
With real time imaging, patients can now view the actual progress on the display while clinicians deliver a safe and precise deposition of energy through a singular energy source that images (sees) and treats the skin and its underlying support structures. Engaging thermal injury to stimulate the wound healing process, intervening healthy tissue from the epidermis down to the point of treatment is mercifully spared, leaving the surface skin virtually free from any possible side-effects. Pain levels have also been greatly reduced compared to its predecessor - Radiofrequency (RF) treatments for collagen. Due to Ulthera's ability to adjust treatment depth with unparalleled accuracy, effective treatment of individual patients, independent of skin colour or thickness, despite variations in facial structure is now possible.
"Presently, with only 150 machines released worldwide, The Sloane Clinic is proud to announce the availability of Ulthera for the first time in Singapore, exclusively at our clinic," says Dr Low Chai Ling. "We strive continually to provide the safest, latest and fastest non-ablative aesthetic treatments for our patients," adds Dr Kenneth Lee.
From a single 30 to 60 minutes full-face treatment, results can last up to four or five years. Recommended follow-up treatments every six months to a year are dependent on individual demands. Normal activity can be resumed immediately after treatment. Patients may follow Ultherapy with Thermage or Fraxel treatments for a more superficial tightening. Due to overwhelming patient demand, Ulthera will only be available exclusively to its existing patients in the interim.
Ulthera answers to the natural evolution in response to the growing demand for safer, more effective modalities with minimized invasiveness and downtime.
About Ulthera Inc.
Ulthera Inc. was founded by a group of ultrasound experts and researchers from Guided Therapy System (GTS) and Johnson & Johnson (J&J). Their initial focus was researching ultrasound for use in the treatment of tumour cells. GTS then broke away from J&J in 2004 to further their research of ultrasound for skin tightening effects. Patented DeepSEE® technology provides physicians a see and treat capability never before experienced in aesthetic medical instrumentation. Intensive research work for the past six years resulted in the unprecedented development of the Ulthera™ System. Extensive measures such as over 1,000 human clinical trials have been undertaken by Ulthera Inc. to ensure the safest and simplest treatment methodology reaches clinicians so to provide the best aesthetic care for its end consumers.
About The Sloane Clinic
The Sloane Clinic is a medical clinic that deals with skin, face and body concerns. Always at the forefront of new technologies, our doctors use advanced, non-invasive cosmetic dermatology techniques and the latest FDA-approved lasers & technology to help our patients improve their appearance, freeing them from the boundaries set by age and society.
The Sloane Clinic is the first clinic in Southeast Asia to introduce the Fraxel Laser, the PPx Photopneumatic Therapy and the Mixto MicroResurfacing Treatment. The clinic is also the first in Southeast Asia to introduce the popular iS Clinical Skincare range, and the first in Singapore to introduce the revolutionary Ultherapy.
Dr Low Chai Ling has been credited with the inception of the Epicuren range and the research and creation of the popular SKIN INC range of cosmeceuticals.
For more information and visuals, please do not hesitate to contact:
Marketing Communications Manager
Desk | 6474 2138
Cell | 9722 1134
Email | elsie(at)sloaneclinic.com
Web | http://www.sloaneclinic.com